Federal Health Minister assails ethics of InSite

September 2008
CMAJ: Canadian Medical Association Journal;9/9/2008, Vol. 179 Issue 6, p521
Academic Journal
The article focuses on the comments of federal Health Minister Tony Clement on medical personnel's support to the Vancouver-based InSite safe injection site in Oregon. Clement states that medical personnel has no ground to support sites where drug addicts can shoot up under medical supervision and emphasizes his concern on the effects of the supervised injection to drug addicts. He also questions whether the involvement of medical personnel in supporting the administration of drugs that are of unknown substance is ethical or not. Meanwhile, medical personnel explains their reasons to support the Vancouver-based InSite safe injection site and concludes that Clement has took advantage to push a political agenda.


Related Articles

  • Lack of Behavior Change after Disclosure of Hepatitis C Virus Infection among Young Injection Drug Users in Baltimore, Maryland. Ompad, Danielle C.; Fuller, Crystal M.; Vlahov, David; Thomas, David; Strathdee, Steffanie A. // Clinical Infectious Diseases;10/1/2002, Vol. 35 Issue 7, p783 

    Investigates the behavior change of young injection drug users in Baltimore, Maryland after being told that they are positive for hepatitis C virus. Absence of change in behavior; Need to development post HCV-test guidelines.

  • A survey of intravenous drug administration by preregistration house officers. Teahon, K.; Bateman, D.N. // BMJ: British Medical Journal (International Edition);9/4/93, Vol. 307 Issue 6904, p605 

    Evaluates the procedures used by preregistration house officers in giving intravenous drugs in Great Britain. Frequency and nature of drug errors; Assessment of the real error rate in medical practice; Accounts of the practicalities of parental drug administration during clinical attachment.

  • Inability to Predict Diagnosis in Febrile Intravenous Drug Abusers. Marantz, Paul R.; Linzer, Mark; Feiner, Cheryl J.; Feinstein, Stuart A.; Kozin, Arthur M.; Friedland, Gerald H. // Annals of Internal Medicine;Jun87, Vol. 106 Issue 6, p823 

    Evaluates the clinical and laboratory data for consecutive admission involving febrile intravenous drug abusers. Difficulties in the diagnosis of the infectious diseases of intravenous drug abusers; Materials and methodology of the study; Discussion on the distribution of diseases.

  • Cocaine Use and the Risk for Endocarditis in Intravenous Drug Users. Chambers, Henry F.; Morris, D. Lynn; Tauber, Martin G.; Modin, Gunnard // Annals of Internal Medicine;Jun87, Vol. 106 Issue 6, p833 

    Compares features in the cases of patients with those in intravenous drug users with other causes of fever to identify risk factors predictive of endocarditis. Methodology of the study; Analysis of clinical data; Discussion on the association between cocaine use and endocarditis.

  • Factors other than the Duke criteria associated with infective endocarditis among injection drug users. Palepu, Anita; Cheung, Stephen S.; Montessori, Valentina; Woods, Ryan; Thompson, Christopher R. // Clinical & Investigative Medicine;Aug2002, Vol. 25 Issue 4, p118 

    Focuses on a study concerning the occurrence of infective endocarditis among injection drug-users (IDU). Utilization of echocardiogram and discharge diagnosis; Symptoms of infective endocarditis; Hospitalization index of IDU in the U.S.

  • Agenda.  // Advocate;11/28/95, Issue 695, p11 

    Presents the percentage of male intravenous drug users who had sex with another man within 30 days of being surveyed for a national study in the United States.

  • Risk Reduction for the Acquired Immunodeficiency Syndrome Among Intravenous Drug Users. Des Jarlais, Don C.; Friedman, Samuel R.; Hopkins, William // Annals of Internal Medicine;Nov85, Vol. 103 Issue 5, p755 

    Examines the reduction of risk for AIDS among intravenous drug users. Number of cases of AIDS in intravenous drug users; Epidemiologic impediments to perceptions of risk; Conclusions.

  • Blood and Plasma Donations Among a Cohort of Intravenous Drug Users. Nelson, Kenrad E.; Vlahov, David; Margolick, Joseph; Bernal, Marie; Taylor, Ellen // JAMA: Journal of the American Medical Association;4/25/90, Vol. 263 Issue 16, p2194 

    Investigates the blood and plasma donation histories of intravenous drug users in Baltimore, Maryland. HIV serologic status; Number of CD4 lymphocytes; Blood donations at commercial plasma centers; Screening for HIV-1; Phlebotomy screening; Demographic and socioeconomic characteristics of...

  • Harm reduction facility faces renewal challenge. MacPhee, Marie- Claire // Network Magazine of the Canadian Women's Health Network;Winter2006, Vol. 9 Issue 1/2, p5 

    The article focuses on the issue of permit renewal which is posing a challenge to the first North American government-sanctioned harm reduction facility Insight, for people who use intravenous drugs in Vancouver, British Columbia. The facility has consumed its three-year term and now requires a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics